Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26,987Revenue $M3,647Net Margin (%)4.5Z-Score4.4
Enterprise Value $M27,834EPS $0.6Operating Margin %3.4F-Score6
P/E(ttm))161Cash Flow Per Share $4.5Pre-tax Margin (%)2.2Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %-11.3Quick Ratio2.3Cash flow > EarningsY
Price/Sales7.45-y EBITDA Growth Rate %-36.3Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow8.0y-y EBITDA Growth Rate %394ROA % (ttm)1.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)2.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M268ROI % (ttm)-1.1Gross Margin Increase y-yY

Gurus Latest Trades with FRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
FRXCarl Icahn 2014-06-30 Sold Out -8.6%$86.76 - $100.04
($93.17)
$ 996%Sold Out0
FRXBill Nygren 2014-06-30 Sold Out -1.4%$86.76 - $100.04
($93.17)
$ 996%Sold Out0
FRXVanguard Health Care Fund 2014-06-30 Reduce-1.25%$86.76 - $100.04
($93.17)
$ 996%Reduce -23.65%15,716,666
FRXDodge & Cox 2014-06-30 Reduce-0.37%$86.76 - $100.04
($93.17)
$ 996%Reduce -98.84%45,100
FRXMario Gabelli 2014-06-30 Reduce-0.03%$86.76 - $100.04
($93.17)
$ 996%Reduce -26.04%183,200
FRXJoel Greenblatt 2014-06-30 Sold Out -0.02%$86.76 - $100.04
($93.17)
$ 996%Sold Out0
FRXMario Gabelli 2014-03-31 Buy 0.12%$58.47 - $99.72
($79.84)
$ 9924%New holding, 247700 sh.247,700
FRXJoel Greenblatt 2014-03-31 Buy 0.02%$58.47 - $99.72
($79.84)
$ 9924%New holding, 11598 sh.11,598
FRXBill Nygren 2014-03-31 Reduce-1.58%$58.47 - $99.72
($79.84)
$ 9924%Reduce -60.61%1,950,000
FRXVanguard Health Care Fund 2014-03-31 Reduce-1.12%$58.47 - $99.72
($79.21)
$ 9925%Reduce -22.81%20,583,766
FRXDodge & Cox 2014-03-31 Reduce-0.24%$58.47 - $99.72
($79.84)
$ 9924%Reduce -49.15%3,888,618
FRXRay Dalio 2014-03-31 Sold Out -0.1%$58.47 - $99.72
($79.84)
$ 9924%Sold Out0
FRXDodge & Cox 2013-12-31 Add0.26%$42.65 - $60.19
($50.29)
$ 9997%Add 122.23%7,647,837
FRXRay Dalio 2013-12-31 Buy 0.1%$42.65 - $60.19
($50.29)
$ 9997%New holding, 201461 sh.201,461
FRXJean-Marie Eveillard 2013-12-31 Add0.05%$42.65 - $60.19
($50.29)
$ 9997%Add 48.83%964,630
FRXRichard Pzena 2013-12-31 Sold Out $42.65 - $60.19
($50.29)
$ 9997%Sold Out0
FRXDodge & Cox 2013-09-30 Buy 0.17%$41.71 - $44.78
($43.47)
$ 99128%New holding, 3441441 sh.3,441,441
FRXJean-Marie Eveillard 2013-09-30 Buy 0.08%$41.71 - $44.78
($43.47)
$ 99128%New holding, 648160 sh.648,160
FRXRichard Pzena 2013-09-30 Reduce-0.25%$41.71 - $44.78
($43.47)
$ 99128%Reduce -98.59%13,075
FRXBill Nygren 2013-06-30 Add0.87%$35.44 - $41.84
($38.64)
$ 99156%Add 65%4,950,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
FRX Jean-Marie Eveillard 2014-06-30806,2300.30.19
FRX Vanguard Health Care Fund 2014-06-3015,716,6665.854.1-23.65%
FRX Mario Gabelli 2014-06-30183,2000.070.1-26.04%
FRX Dodge & Cox 2014-06-3045,1000.020-98.84%
FRX Bill Nygren 2014-06-30000Sold Out
FRX Joel Greenblatt 2014-06-30000Sold Out
FRX Carl Icahn 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


FRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Forest Laboratories, LLC10% Owner 2014-07-02Buy11,169,066$954.21view
Forest Laboratories Holdings L10% Owner 2014-02-05Buy428,571$71314.29view
SOLOMON HOWARDDirector 2014-01-27Sell250,000$65.4151.35view
SOLOMON HOWARDDirector 2014-01-23Sell250,000$67.1347.48view
Lynch JeromeSVP-Sales 2014-01-22Sell135,625$67.2847.15view
OLANOFF LAWRENCE SDirector 2013-08-26Sell1,104$42.96130.45view
Francis Perier I JrEVP Finance & Admin. & CFO 2013-08-21Sell12,000$43130.23view
Basgoz NesliDirector 2013-03-07Sell12,200$37.46164.28view
OLANOFF LAWRENCE SDirector 2013-03-04Sell543$36.77169.24view
Meury WilliamSVP - Marketing 2013-02-06Sell26,350$35.73177.08view

Press Releases about FRX :

    Quarterly/Annual Reports about FRX:

    News about FRX:

    Articles On GuruFocus.com
    Bernard Horn Comments on Forest Laboratories Aug 26 2014 
    Bernard Horn’s Polaris Global Value Fund 2Q 2014 Message to Our Shareholders Aug 26 2014 
    Global Guru Bernard Horn Reports his Top Five from the Second Quarter Aug 22 2014 
    Guru of the Year – Carl Icahn’s Top Five Holdings Aug 17 2014 
    Bernard Horn Comments on Forest Laboratories Aug 07 2014 
    Diamond Hill Capital Comments on Forest Laboratories Inc Jun 26 2014 
    GuruFocus Guru of the 2013 Carl Icahn's Top First Quarter Holdings May 15 2014 
    International Guru Bernard Horn Reports His Top Five in the First Quarter May 07 2014 
    Mario Gabelli’s GAMCO Investors Top 5 New Stocks May 07 2014 
    Dodge & Cox First Quarter 2014 Commentary May 06 2014 

    More From Other Websites
    Drugmakers Shire, AbbVie near $53B merger Jul 14 2014
    FOREST LABORATORIES, LLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion... Jul 03 2014
    Forest Laboratories, Inc. -- Moody's upgrades bonds of Forest Labs to Baa3 Jul 01 2014
    Actavis closes $28B Forest deal, names new CEO Jul 01 2014
    Actavis closes $28B Forest deal, names new CEO Jul 01 2014
    [video] Actavis completes deal to buy Forest Labs Jul 01 2014
    Actavis Completes Forest Laboratories Acquisition Jul 01 2014
    Actavis Completes Forest Laboratories Acquisition Jul 01 2014
    U.S. allows Actavis Plc's purchase of Forest Labs with conditions Jun 30 2014
    Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest Jun 30 2014
    Actavis, Forest Labs announce merger consideration election results Jun 30 2014
    Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results Jun 30 2014
    Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results Jun 30 2014
    Affiliated Managers Group Set to Join S&P 500; LaSalle Hotel Properties, Rayonier Advanced... Jun 24 2014
    Forest Laboratories Reports Positive Data on Viibryd Jun 24 2014
    After-hours buzz: Bristol-Myers Squibb, Walgreen & More Jun 24 2014
    Actavis and Forest Announce Tentative Election Deadline Of June 27, 2014 Jun 24 2014
    Actavis and Forest Announce Tentative Election Deadline of June 27, 2014 Jun 24 2014
    Forest antidepressant Viibryd succeeds in anxiety disorder trials Jun 23 2014
    3 Stocks Driving The Health Care Sector Higher Jun 23 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Cjs804
    ReplyCjs804 - 7 months ago
    pfe
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK